The somatotrophic system in patients with dilated cardiomyopathy: Relation of insulin‐like growth factor‐1 and its alterations during growth hormone therapy to cardiac function

Treatment with human recombinant growth hormone has yielded conflicting results in patients with congestive heart failure. In addition, growth hormone resistance has been reported in severe heart failure. Therefore, the purpose of this study was to evaluate the somatotrophic axis and effects of growth hormone on haemodynamics in patients with heart failure due to dilated cardiomyopathy.

[1]  R. Dietz,et al.  Role of nitric oxide in the vasodilator effect of recombinant human growth hormone in patients with dilated cardiomyopathy. , 2000, Cardiovascular research.

[2]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[3]  M. Morello,et al.  Activity of GH/IGF‐I axis in patients with dilated cardiomyopathy , 1999, Journal of endocrinological investigation.

[4]  JürgenMeyer,et al.  Recombinant Growth Hormone Therapy in Patients With Ischemic Cardiomyopathy , 1999 .

[5]  B. Lorell,et al.  Treatment with growth hormone enhances contractile reserve and intracellular calcium transients in myocytes from rats with postinfarction heart failure. , 1999, Circulation.

[6]  T. Voigtländer,et al.  Recombinant growth hormone therapy in patients with ischemic cardiomyopathy : effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity. , 1999, Circulation.

[7]  M. Lomsky,et al.  A placebo-controlled study of growth hormone in patients with congestive heart failure. , 1998, European heart journal.

[8]  P. Poole‐Wilson,et al.  Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy , 1998, The Lancet.

[9]  K. Michaelsen,et al.  Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency. , 1997, The Journal of clinical endocrinology and metabolism.

[10]  P. Ponikowski,et al.  Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. , 1997, Circulation.

[11]  D. Green,et al.  Treatment of end-stage cardiac failure with growth hormone , 1997, The Lancet.

[12]  M. Volterrani,et al.  Haemodynamic effects of intravenous growth hormone in congestive heart failure , 1997, The Lancet.

[13]  B. Tönshoff,et al.  Derangements of the somatotropic hormone axis in chronic renal failure. , 1997, Kidney international. Supplement.

[14]  G. Brabant,et al.  Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study. , 1996, The Journal of clinical investigation.

[15]  M. Russo,et al.  Growth hormone in the treatment of dilated cardiomyopathy. , 1996, The New England journal of medicine.

[16]  P. Douglas,et al.  Exogenously administered growth hormone and insulin-like growth factor-I alter intracellular Ca2+ handling and enhance cardiac performance. In vitro evaluation in the isolated isovolumic buffer-perfused rat heart. , 1996, Circulation research.

[17]  F. Barillà,et al.  [Changes in growth hormone/insulin-like growth factor-1 axis in patients with normal pituitary function and biventricular cardiac failure and hepatic stasis]. , 1996, Cardiologia.

[18]  B. Biondi,et al.  A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. , 1996, The New England journal of medicine.

[19]  R J Batista,et al.  Partial Left Ventriculectomy to Improve Left Ventricular Function in End‐Stage Heart Disease , 1996, Journal of cardiac surgery.

[20]  O. Alfieri,et al.  Impaired spontaneous growth hormone secretion in severe dialated cardiomyopathy. , 1996, American heart journal.

[21]  P. Douglas,et al.  Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation. , 1996, Circulation.

[22]  B. Tönshoff,et al.  Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2, and 3 in children with chronic renal failure: relationship to height and glomerular filtration rate. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. , 1995, The Journal of clinical endocrinology and metabolism.

[23]  M C Oz,et al.  Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. , 1995, Circulation.

[24]  P. Grayburn,et al.  Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. , 1995, Journal of the American College of Cardiology.

[25]  J. Holly,et al.  Growth hormone, insulinlike growth factor‐1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease , 1995, Hepatology.

[26]  S. Coughlin,et al.  Idiopathic dilated cardiomyopathy. , 1994, The New England journal of medicine.

[27]  B. Breier,et al.  Radioimmunoassays for IGFs and IGFBPs. , 1994, Growth regulation.

[28]  J. Ketelslegers,et al.  Nutritional regulation of the insulin-like growth factors. , 1994, Endocrine reviews.

[29]  E. Rutanen,et al.  Insulin-like growth factors and their binding proteins. , 1990, Acta endocrinologica.

[30]  P. Poole‐Wilson.  Idiopathic dilated cardiomyopathy. , 1990, BMJ.

[31]  J. Kresh,et al.  Left ventricular volumes using cine-MRI : validation by catheterization ventriculography , 1990 .

[32]  C. Higgins,et al.  Noninvasive evaluation of global left ventricular function with use of cine nuclear magnetic resonance. , 1989, Journal of the American College of Cardiology.

[33]  B. Sherman,et al.  Variability in the quantitation of circulating growth hormone using commercial immunoassays. , 1989, The Journal of clinical endocrinology and metabolism.

[34]  H. Orskov,et al.  Increased myocardial contractility following growth hormone administration in normal man. An echocardiographic study. , 1988, Danish medical bulletin.

[35]  R M Peshock,et al.  Left ventricular volumes measured by MR imaging. , 1985, Radiology.

[36]  H. Pech.  Quantitative angiocardiography of the normal left ventricle. , 1973, Cor et vasa.

[37]  Harold T. Dodge,et al.  Quantitative Angiocardiography: I. The Normal Left Ventricle in Man , 1966, Circulation.

[38]  G. A. Moore,et al.  Effect of captopril on functional mitral regurgitation in dilated heart failure: a randomised double blind placebo controlled trial. , 1994, British heart journal.